- Home
- IZM vs EVOK Comparison
IZM vs EVOK Comparison
Compare IZM & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IZM | EVOK |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 18.4M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | IZM | EVOK |
|---|---|---|
| Price | $1.05 | $10.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 54.6K | 30.8K |
| Earning Date | 10-24-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $187,048,691.00 | $14,424,652.00 |
| Revenue This Year | N/A | $58.96 |
| Revenue Next Year | N/A | $57.99 |
| P/E Ratio | $10.60 | ★ N/A |
| Revenue Growth | 5.12 | ★ 67.40 |
| 52 Week Low | $0.87 | $1.94 |
| 52 Week High | $2.74 | $11.00 |
Technical Indicators
Market Signals| Indicator | IZM | EVOK |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 85.30 |
| Support Level | $0.89 | $10.66 |
| Resistance Level | $1.25 | $10.99 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | 0.05 | -0.18 |
| Stochastic Oscillator | 59.37 | 100.00 |
Price Performance
Historical ComparisonAbout IZM ICZOOM Group Inc.
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.